Protagonist Stock 120%, Fund Outlook and Exit Signals
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
We compare expense ratios across dividend growth ETFs to identify the lowest-cost options for long-term investing.
28,176 articlesA hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
The S&P 500 tests major support as volatility eases and a fresh buy signal emerges. Traders weigh a possible near-ter...
Cardano moves to public testing for a scaling upgrade while ADA slides and a wallet exploit tests user trust, widenin...
Micron stock sinking today signals short-term selling pressure in a volatile memory market. This article breaks down ...
Berkshire Hathaway ramps up buybacks and sits on a large cash cushion, while Pershing Square slips 16% year-to-date a...
GoPro faces rising costs and fierce rivals as it accelerates a shift toward services and smarter supply chains to dri...
Carlisle Companies stands out as a strong contender in the building products arena thanks to its diversified mix, dis...
Buyers who wait for the perfect dip in housing are facing rising rents and missed appreciation. This report breaks do...
A looming funding gap could push policymakers toward fixes that feel like benefit cuts to millions. Learn what this p...
The AI era hinges on faster data movement and scalable hardware. This article explains why optical networking could b...
When a beloved soap star hints at a fragile return, it isn’t just headlines that shake. It can ripple into budgets, i...
Gas prices are reshaping how Americans travel. This article explains the surge in carpooling, highlights a stock buil...